- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 251/76 - Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
Patent holdings for IPC class C07C 251/76
Total number of patents in this class: 39
10-year publication summary
|
1
|
4
|
2
|
3
|
4
|
2
|
3
|
4
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shenzhen Cell Inspire Pharmaceutical Development Co., Ltd. | 8 |
3 |
| Janssen Pharmaceutica N.V. | 3349 |
2 |
| Id4pharma, LLC | 7 |
2 |
| Genevant Sciences GmbH | 59 |
2 |
| ReNAgade Therapeutics Management Inc. | 44 |
2 |
| BASF SE | 21080 |
1 |
| Sandoz AG | 1419 |
1 |
| AstraZeneca AB | 2857 |
1 |
| Syngenta Participations AG | 1749 |
1 |
| Syngenta Limited | 448 |
1 |
| Sumitomo Chemical Company, Limited | 9095 |
1 |
| The Regents of the University of Michigan | 4763 |
1 |
| The Johns Hopkins University | 5739 |
1 |
| Adeka Corporation | 1366 |
1 |
| Asubio Pharma Co., Ltd. | 27 |
1 |
| B.G. Negev Technologies and Applications Ltd., at Ben-gurion University | 364 |
1 |
| Children's Hospital Medical Center | 733 |
1 |
| China Agricultural University | 306 |
1 |
| Eastern Michigan University | 32 |
1 |
| FMC Corporation | 834 |
1 |
| Other owners | 13 |